Expression and Function of Histone Deacetylase 10 (HDAC10) in B Cell Malignancies
John Powers1,2, Maritza Lienlaf1, Patricio Perez-Villarroel1
1Department of Immunology, H. Lee Moffitt Cancer Center & Research Institute, SRB-2 Room 22344A2, 12902 Magnolia Drive, Tampa, FL, USA.
Abstract:
Histone deacetylase 10 (HDAC10) belongs to the class IIb HDAC family and its biological role remains mostly unidentified. A decreased HDAC10 expression has been reported in patients with aggressive solid tumors (Osada et al. Int J Cancer 112: 26-32, 2004; Jin et al. Int J Clin Exp Pathol 7: 5872-5879, 2014), suggesting that loss of HDAC10 expression might confer a survival advantage to malignant cells. Consequently, results from our lab suggests that overexpression of HDAC10 in aggressive mantle cell lymphoma (MCL) and chronic lymphocytic leukemia (CLL) Z138c and MEC1 cells, respectively, resulted in a rapid induction of cell death in vitro with only 5 % of cells being alive at 48 h, cell cycle arrest, and up-regulation of co-stimulatory molecules. Here we present several standard methods to study the function of HDAC10 in B cell malignancies.
Insights
Overexpressing Histone deacetylase 10 (HDAC10) in aggressive B cell lymphomas induced rapid cell death and cell cycle arrest. This suggests HDAC10’s potential role in targeting malignant cells.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Histone deacetylase 10 (HDAC10) is a class IIb enzyme with an uncharacterized biological role.
- Reduced HDAC10 expression is observed in aggressive solid tumors, hinting at its tumor-suppressive function.
- The role of HDAC10 in B cell malignancies like mantle cell lymphoma (MCL) and chronic lymphocytic leukemia (CLL) is largely unknown.
Purpose of the Study:
- To investigate the function of HDAC10 in B cell malignancies.
- To explore the therapeutic potential of HDAC10 modulation in MCL and CLL.
Main Methods:
- Overexpression of HDAC10 in MCL (Z138c) and CLL (MEC1) cell lines.
- Assessment of cell viability and cell cycle progression.
- Analysis of co-stimulatory molecule expression.
Main Results:
- HDAC10 overexpression led to rapid cell death in MCL and CLL cells within 48 hours (only 5% viability).
- HDAC10 induction caused cell cycle arrest in these malignant B cells.
- Co-stimulatory molecule expression was significantly upregulated following HDAC10 overexpression.
Conclusions:
- HDAC10 functions as a tumor suppressor in B cell malignancies.
- Targeting HDAC10 may represent a novel therapeutic strategy for MCL and CLL.
- Further studies are warranted to elucidate the precise mechanisms of HDAC10 action in these cancers.
Related Concept Videos
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Histone Modification
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Spreading of Chromatin Modifications
Writers
The writer...
Abnormal Proliferation
Regulation of Hematopoietic Stem Cells


